Evidence map›Paper›PMID 35651700›Full record

ArticleBeilstein journal of organic chemistry2022

Shift of the reaction equilibrium at high pressure in the continuous synthesis of neuraminic acid.

Jannis A Reich, Miriam Aßmann, Kristin Hölting, Paul Bubenheim, Jürgen Kuballa, Andreas Liese

Open access · diamondAbstract read
In one paragraph

Article in Beilstein journal of organic chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jannis A Reich *Institute of Technical Biocatalysis, Hamburg University of Technology, Denickestr. 15, 21073 Hamburg, Germany.ORCID https://orcid.org/0000-0002-6374-6630
Miriam Aßmann *GALAB Laboratories GmbH, Am Schleusengraben 7, 21029 Hamburg, Germany.ORCID https://orcid.org/0000-0002-1660-5253
Kristin HöltingGALAB Laboratories GmbH, Am Schleusengraben 7, 21029 Hamburg, Germany.
Paul BubenheimInstitute of Technical Biocatalysis, Hamburg University of Technology, Denickestr. 15, 21073 Hamburg, Germany.
Jürgen KuballaGALAB Laboratories GmbH, Am Schleusengraben 7, 21029 Hamburg, Germany.
Andreas LieseInstitute of Technical Biocatalysis, Hamburg University of Technology, Denickestr. 15, 21073 Hamburg, Germany.ORCID https://orcid.org/0000-0002-4867-9935
GALAB Laboratories (Germany) · DEUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The importance of a compound that helps fight against influenza is, in times of a pandemic, self-evident. In order to produce these compounds in vast quantities, many researchers consider continuous flow reactors in chemical industry as next stepping stone for large scale production. For these reasons, the synthesis of

Indexed as

aldolasecontinuous fixed-bed reactorenzymeepimeraseGlcNAchigh pressureimmobilizationManNAcNeu5Acpyruvate

Identifiers

PMID35651700
PMCPMC9127241
OpenAlexW4280646217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.